Inventprise

Inventprise

Edit info

  • Founded: 2012
  • Location: Redmond, WA
  • Employee range: 50 - 200
  • Clinical stage: Clin1
  • Therapy area: Pneumococcal Conjugate Vaccine
  • Drug types: INF, VAC
  • Lead product: PCV-25
  • Funding: $30M Apr 2022
  • Investors: Bill & Melinda Gates Foundation


inventprise.com

linkedin.com

job board


Business:

Vaccines

Drug notes:

GBS-06 Clin0 Strep; Shigella-04 RD Shigella; Klebsiella vaccine RD Klebsiella; RSV Vaccine RD RSV

About:

Inventprise is developing innovative and affordable vaccines to bring health to the masses and provide protection against pathogenic strains of infectious diseases. Using their Linker Conjugation platform, Inventprise is creating vaccines that last-longer within patients enabling better coverage and a stronger immune response to be generated. The platform uses their proprietary scalable conjugation technology that can be used to create highly immunogenic and broad spectrum conjugate vaccines. Inventprise’s lead candidate, PCV-25, is a Pneumococcal Conjugate Vaccine, however their robust pipeline also includes investigational vaccines for group B streptococcus and Shigella.

Inventprise
Environmental Health and Safety Manager
Woodinville, Washington|24 days ago
Apply
Inventprise
Environmental Monitoring Technician II
Woodinville, Washington|25 days ago


© 2025 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com